Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,041 shares at $85.51 ($90K) on 2015-10-20, disclosed to the SEC on 2015-10-21.
Scheduled sale ($90k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.94 | 392 | $35K | 38.6% |
| 2 | $85.51 | 649 | $55K | 61.4% |
| Total | $86.80 avg | 1,041 | $90K | 100% |
| Filing → |
| RARE | SELL | 2016-07-21 | $34K | — | Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |